842
Views
1
CrossRef citations to date
0
Altmetric
Report

Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli

, , , , , , & show all
Pages 1084-1093 | Received 11 Dec 2013, Accepted 24 Mar 2014, Published online: 27 Mar 2014

References

  • Taylor P, Radic Z, Hosea NA, Camp S, Marchot P, Berman HA. Structural bases for the specificity of cholinesterase catalysis and inhibition. Toxicol Lett 1995; 82-83:453 - 8; http://dx.doi.org/10.1016/0378-4274(95)03575-3; PMID: 8597093
  • Shafferman A, Ordentlich A, Barak D, Stein D, Ariel N, Velan B. Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre. Biochem J 1996; 318:833 - 40; PMID: 8836126
  • Aurbek N, Herkert NM, Koller M, Thiermann H, Worek F. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?. Chem Biol Interact 2010; 187:215 - 9; http://dx.doi.org/10.1016/j.cbi.2010.01.035; PMID: 20105433
  • Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002; 76:523 - 9; http://dx.doi.org/10.1007/s00204-002-0375-1; PMID: 12242610
  • Bird SB, Dawson A, Ollis D. Enzymes and bioscavengers for prophylaxis and treatment of organophosphate poisoning. [Schol Ed] Front Biosci (Schol Ed) 2010; 2:209 - 20; http://dx.doi.org/10.2741/s58; PMID: 20036941
  • Trovaslet-Leroy M, Musilova L, Renault F, Brazzolotto X, Misik J, Novotny L, Froment MT, Gillon E, Loiodice M, Verdier L, et al. Organophosphate hydrolases as catalytic bioscavengers of organophosphorus nerve agents. Toxicol Lett 2011; 206:14 - 23; http://dx.doi.org/10.1016/j.toxlet.2011.05.1041; PMID: 21683774
  • Kurkova IN, Smirnov IV, Belogurov AA Jr., Ponomarenko NA, Gabibov AG. Creation of catalytic antibodies metabolizing organophosphate compounds. Biochemistry (Mosc) 2012; 77:1139 - 46; http://dx.doi.org/10.1134/S0006297912100069; PMID: 23157294
  • Otto TC, Scott JR, Kauffman MA, Hodgins SM, Ditargiani RC, Hughes JH, Sarricks EP, Saturday GA, Hamilton TA, Cerasoli DM. Identification and characterization of novel catalytic bioscavengers of organophosphorus nerve agents. Chem Biol Interact 2013; 203:186 - 90; http://dx.doi.org/10.1016/j.cbi.2012.09.009; PMID: 23041042
  • Smirnov I, Belogurov A Jr., Friboulet A, Masson P, Gabibov A, Renard PY. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents. Chem Biol Interact 2013; 203:196 - 201; http://dx.doi.org/10.1016/j.cbi.2012.10.011; PMID: 23123255
  • Petrikovics I, McGuinn WD, Sylvester D, Yuzapavik P, Jiang J, Way JL, Papahadjopoulos D, Hong K, Yin R, Cheng TC, et al. In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism. Drug Deliv 2000; 7:83 - 9; http://dx.doi.org/10.1080/107175400266641; PMID: 10892408
  • Szilasi M, Budai M, Budai L, Petrikovics I. Nanoencapsulated and microencapsulated enzymes in drug antidotal therapy. Toxicol Ind Health 2012; 28:522 - 31; http://dx.doi.org/10.1177/0748233711416946; PMID: 21986886
  • Cohen O, Kronman C, Raveh L, Mazor O, Ordentlich A, Shafferman A. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Mol Pharmacol 2006; 70:1121 - 31; http://dx.doi.org/10.1124/mol.106.026179; PMID: 16801396
  • Masson P, Lockridge O. Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior. Arch Biochem Biophys 2010; 494:107 - 20; http://dx.doi.org/10.1016/j.abb.2009.12.005; PMID: 20004171
  • Mumford H, Docx CJ, Price ME, Green AC, Tattersall JE, Armstrong SJ. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning. Chem Biol Interact 2013; 203:160 - 6; http://dx.doi.org/10.1016/j.cbi.2012.08.018; PMID: 22981459
  • Cerasoli DM, Griffiths EM, Doctor BP, Saxena A, Fedorko JM, Greig NH, Yu QS, Huang Y, Wilgus H, Karatzas CN, et al. In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chem Biol Interact 2005; 157-158:363 - 5; http://dx.doi.org/10.1016/j.cbi.2005.10.052; PMID: 16429486
  • Mumford H, Troyer JK. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs. Toxicol Lett 2011; 206:29 - 34; http://dx.doi.org/10.1016/j.toxlet.2011.05.1016; PMID: 21620937
  • Petroianu GA, Arafat K, Nurulain SM, Kuca K, Kassa J. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon. J Appl Toxicol 2007; 27:168 - 75; http://dx.doi.org/10.1002/jat.1189; PMID: 17265452
  • Prasad SB, Kumar YC, Kumar CS, Sadashiva CT, Vinaya K, Rangappa KS. Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors. Open Med Chem J 2007; 1:4 - 10; http://dx.doi.org/10.2174/1874104500701010004; PMID: 19662135
  • Malik A, Firoz A, Jha V, Sunderasan E, Ahmad S. Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin. J Mol Model 2010; 16:1883 - 93; http://dx.doi.org/10.1007/s00894-010-0680-1; PMID: 20232097
  • Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, et al. The protein data bank. Acta Crystallogr D Biol Crystallogr 2002; 58:899 - 907; http://dx.doi.org/10.1107/S0907444902003451; PMID: 12037327
  • Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673 - 80; http://dx.doi.org/10.1093/nar/22.22.4673; PMID: 7984417
  • Sivasubramanian A, Sircar A, Chaudhury S, Gray JJ. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 2009; 74:497 - 514; http://dx.doi.org/10.1002/prot.22309; PMID: 19062174
  • Cole C, Barber JD, Barton GJ. The Jpred 3 secondary structure prediction server. Nucleic Acids Res 2008; 36:W197 201; http://dx.doi.org/10.1093/nar/gkn238; PMID: 18463136
  • Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22:195 - 201; http://dx.doi.org/10.1093/bioinformatics/bti770; PMID: 16301204
  • Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 2004; 60:2256 - 68; http://dx.doi.org/10.1107/S0907444904026460; PMID: 15572779
  • Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem 1993; 268:17083 - 95; PMID: 8349597
  • Taguchi H, Planque S, Sapparapu G, Boivin S, Hara M, Nishiyama Y, Paul S. Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds. J Biol Chem 2008; 283:36724 - 33; http://dx.doi.org/10.1074/jbc.M806766200; PMID: 18974093
  • Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ. Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function. J Comput Chem 1998; 19:1639 - 62; http://dx.doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
  • Pauling L. Antibodies and specific biological forces. Endeavour 1948; 7:43 - 53; PMID: 18916790
  • Pollack SJ, Jacobs JW, Schultz PG. Selective chemical catalysis by an antibody. Science 1986; 234:1570 - 3; http://dx.doi.org/10.1126/science.3787262; PMID: 3787262
  • Tramontano A, Janda KD, Lerner RA. Catalytic antibodies. Science 1986; 234:1566 - 70; http://dx.doi.org/10.1126/science.3787261; PMID: 3787261
  • Nieri P, Donadio E, Rossi S, Adinolfi B, Podestà A. Antibodies for therapeutic uses and the evolution of biotechniques. Curr Med Chem 2009; 16:753 - 79; http://dx.doi.org/10.2174/092986709787458380; PMID: 19199935
  • Izadyar L, Friboulet A, Remy MH, Roseto A, Thomas D. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc Natl Acad Sci U S A 1993; 90:8876 - 80; http://dx.doi.org/10.1073/pnas.90.19.8876; PMID: 8415624
  • Johnson G, Moore SW. Catalytic antibodies with acetylcholinesterase activity. J Immunol Methods 2002; a 269:13 - 28; http://dx.doi.org/10.1016/S0022-1759(02)00222-3; PMID: 12379349
  • Johnson G, Moore SW. Idiotypic mimicry of a catalytic antibody active site. Mol Immunol 2002; b 39:273 - 88; http://dx.doi.org/10.1016/S0161-5890(02)00113-X; PMID: 12220886
  • Franqueville E, Stamatis H, Loutrari H, Friboulet A, Kolisis F. Studies on the catalytic behaviour of a cholinesterase-like abzyme in an AOT microemulsion system. J Biotechnol 2002; 97:177 - 82; http://dx.doi.org/10.1016/S0168-1656(02)00061-5; PMID: 12067523
  • Wahler D, Reymond JL. Novel methods for biocatalyst screening. Curr Opin Chem Biol 2001; 5:152 - 8; http://dx.doi.org/10.1016/S1367-5931(00)00184-8; PMID: 11282341
  • Soumillion P, Fastrez J. Novel concepts for selection of catalytic activity. Curr Opin Biotechnol 2001; 12:387 - 94; http://dx.doi.org/10.1016/S0958-1669(00)00232-9; PMID: 11551468
  • Shokat KM, Schultz PG. Catalytic antibodies. Methods Enzymol 1991; 203:327 - 51; http://dx.doi.org/10.1016/0076-6879(91)03019-D; PMID: 1762563
  • Janda KD. New strategies for the design of catalytic antibodies. Biotechnol Prog 1990; 6:178 - 81; http://dx.doi.org/10.1021/bp00003a002; PMID: 1366610
  • Nixon AE, Sexton DJ, Ladner RC. Drugs derived from phage display: From candidate identification to clinical practice. MAbs 2013; 6; Forthcoming PMID: 24262785
  • Smart JL, McCammon JA. Analysis of synaptic transmission in the neuromuscular junction using a continuum finite element model. Biophys J 1998; 75:1679 - 88; http://dx.doi.org/10.1016/S0006-3495(98)77610-6; PMID: 9746510
  • Noori HR, Fliegel S, Brand I, Spanagel R. The impact of acetylcholinesterase inhibitors on the extracellular acetylcholine concentrations in the adult rat brain: a meta-analysis. Synapse 2012; 66:893 - 901; http://dx.doi.org/10.1002/syn.21581; PMID: 22733599
  • Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Chem Biol Interact 1999; 119-120:61 - 9; http://dx.doi.org/10.1016/S0009-2797(99)00014-9; PMID: 10421439
  • Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978; 28:266 - 72; http://dx.doi.org/10.1212/WNL.28.3.266; PMID: 564482
  • De Baets M, Stassen MH. The role of antibodies in myasthenia gravis. J Neurol Sci 2002; 202:5 - 11; http://dx.doi.org/10.1016/S0022-510X(02)00200-9; PMID: 12220686
  • Hughes BW, Moro De Casillas ML, Kaminski HJ. Pathophysiology of myasthenia gravis. Semin Neurol 2004; 24:21 - 30; http://dx.doi.org/10.1055/s-2004-829585; PMID: 15229789
  • de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat Biotechnol 2000; 18:989 - 94; http://dx.doi.org/10.1038/79494; PMID: 10973222
  • Ellman GL, Courtney KD, Andres V Jr., Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7:88 - 95; http://dx.doi.org/10.1016/0006-2952(61)90145-9; PMID: 13726518
  • Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem 2003; 312:224 - 7; http://dx.doi.org/10.1016/S0003-2697(02)00506-7; PMID: 12531209
  • Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 2011; 39:W270 7; http://dx.doi.org/10.1093/nar/gkr366; PMID: 21624888
  • Gasteiger J, Marsili M. Iterative Partial Equalization of Orbital Electronegativity - A Rapid Access to Atomic Charges. Tetrahedron 1980; 36:3219 - 28; http://dx.doi.org/10.1016/0040-4020(80)80168-2
  • Solis FJ, Wets RJB. Minimization by random search techniques. Math Operat Res 1981; 6:19 30; http://dx.doi.org/10.1287/moor.6.1.19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.